Guardian Life Insurance Company of America continues its present coverage guidelines for mammography screenings

NewsGuard 100/100 Score

The Guardian Life Insurance Company of America (Guardian), one of the largest mutual life insurers and a leading provider of employee benefits for small and mid-sized companies, today announced that the company will continue to follow its current insurance coverage guidelines for mammography screenings. These guidelines are consistent with the American Cancer Society and American Medical Association (AMA) recommendations for mammography screenings.

Recently, The U.S. Preventive Services Task Force recommended increasing the age for and decreasing the frequency of mammography screenings.

"Guardian is committed to promoting preventative services and overall wellness to help its members lead longer and healthier lives," said Tim Bireley, vice president, Guardian Group Medical. "We believe that mammography continues to be an important tool in diagnosing breast cancer. Guardian respects the relationship between its clients and their physicians and encourages women to meet with their doctors to discuss when they should begin breast cancer screenings."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Do neighborhood-level disparities in breast cancer–specific survival remain after accounting for individual, tumor, and treatment characteristics?